3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
22 23 0 1 0 0 0 0 0999 V2000
3.7238 0.9519 0.7270 O 0 0 0 0 0 0 0 0 0 0 0 0
1.4980 0.2332 0.8472 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.1099 -0.7127 0.6003 N 0 0 0 0 0 0 0 0 0 0 0 0
0.6479 -0.6957 0.1401 C 0 0 2 0 0 0 0 0 0 0 0 0
1.3315 -0.8121 -1.2191 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8093 -0.6101 -0.8947 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7940 -0.2666 0.0688 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7771 0.3062 0.3050 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1595 0.9159 -0.5648 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7981 -1.0385 0.6307 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4991 1.2850 -0.6165 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4270 0.4436 -0.0241 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7336 -1.6511 0.6740 H 0 0 0 0 0 0 0 0 0 0 0 0
1.0154 -0.0296 -1.9192 H 0 0 0 0 0 0 0 0 0 0 0 0
1.1384 -1.7751 -1.7028 H 0 0 0 0 0 0 0 0 0 0 0 0
3.3494 -0.1501 -1.7257 H 0 0 0 0 0 0 0 0 0 0 0 0
3.2890 -1.5510 -0.6078 H 0 0 0 0 0 0 0 0 0 0 0 0
1.2277 0.7155 1.6990 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.4163 1.5688 -1.0137 H 1 0 0 0 0 0 0 0 0 0 0 0
-1.5779 -1.9723 1.1388 H 1 0 0 0 0 0 0 0 0 0 0 0
-2.8070 2.2036 -1.1027 H 1 0 0 0 0 0 0 0 0 0 0 0
-4.4844 0.6867 -0.0364 H 1 0 0 0 0 0 0 0 0 0 0 0
1 8 2 0 0 0 0
2 4 1 0 0 0 0
2 8 1 0 0 0 0
2 18 1 0 0 0 0
3 10 1 0 0 0 0
3 12 2 0 0 0 0
4 5 1 0 0 0 0
4 7 1 0 0 0 0
4 13 1 0 0 0 0
5 6 1 0 0 0 0
5 14 1 0 0 0 0
5 15 1 0 0 0 0
6 8 1 0 0 0 0
6 16 1 0 0 0 0
6 17 1 0 0 0 0
7 9 1 0 0 0 0
7 10 2 0 0 0 0
9 11 2 0 0 0 0
9 19 1 0 0 0 0
10 20 1 0 0 0 0
11 12 1 0 0 0 0
11 21 1 0 0 0 0
12 22 1 0 0 0 0
M ISO 4 19 2 20 2 21 2 22 2
4. 国际命名与标识
4.1 IUPAC Name
5-(2,4,5,6-tetradeuteriopyridin-3-yl)pyrrolidin-2-one
4.2 InChl
InChI=1S/C9H10N2O/c12-9-4-3-8(11-9)7-2-1-5-10-6-7/h1-2,5-6,8H,3-4H2,(H,11,12)/i1D,2D,5D,6D
4.3 InChlKey
FXFANIORDKRCCA-NMRLXUNGSA-N
4.4 Canonical SMILES
C1CC(=O)NC1C2=CN=CC=C2
4.5 lsomeric SMILES
[2H]C1=C(C(=C(N=C1[2H])[2H])C2CCC(=O)N2)[2H]
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病